OTCMKTS:CRNCV Cerence (CRNCV) Stock Price, News & Analysis $2.82 -0.15 (-5.05%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlines About Cerence Stock (OTCMKTS:CRNCV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cerence alerts:Sign Up Key Stats Today's Range$2.80▼$3.1250-Day Range$2.44▼$3.8052-Week Range$17.25▼$29.36Volume943,150 shsAverage Volume75,989 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewRead More… “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Receive CRNCV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cerence and its competitors with MarketBeat's FREE daily newsletter. Email Address CRNCV Stock News HeadlinesCytoDyn announces FDA clearance of Phase II oncology trialNovember 4, 2024 | markets.businessinsider.comCRC Expands Medical Leadership Team with Appointment of Accomplished Medical DirectorsSeptember 24, 2024 | finance.yahoo.comBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…November 21, 2024 | Crypto 101 Media (Ad)ESMO 2024: Natera showcases chemotherapy prediction benefit of cDNA testSeptember 16, 2024 | finance.yahoo.comCerence Inc. (CRNC)May 24, 2024 | finance.yahoo.comVeritext Legal Solutions Offers Webinar on “AI and the Record for Reporters and Videographers”March 30, 2024 | finance.yahoo.comHome minister: Rulers wanted tighter citizenship conditions; Bill not about denying humanitarian aspectMarch 29, 2024 | msn.comStrong Buy Rating for Enliven Therapeutics Backed by Innovative Drug Candidates and Financial StabilityMarch 16, 2024 | markets.businessinsider.comSee More Headlines CRNCV Stock Analysis - Frequently Asked Questions How have CRNCV shares performed this year? Cerence's stock was trading at $19.66 at the start of the year. Since then, CRNCV shares have decreased by 85.7% and is now trading at $2.82. View the best growth stocks for 2024 here. How do I buy shares of Cerence? Shares of CRNCV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Packaged Software Sub-IndustryN/A Current SymbolOTCMKTS:CRNCV CUSIPN/A CIKN/A Webwww.cerence.com PhoneN/AFaxN/AEmployees1,300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report This page (OTCMKTS:CRNCV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerence Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerence With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
